Semaglutide

MIAMI, Fla., July 27, 2026 Veru Inc. announced the successful completion of patient enrollment in its Phase 2b PLATEAU...

BAGSVÆRD, Denmark, July 15, 2026 Novo Nordisk has achieved a major regulatory milestone after the European Commission (EC) granted...

ALAMEDA, Calif., July 7, 2026 Vivani Medical, Inc. has entered into a new strategic agreement with Novo Nordisk to...

MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...

TORONTO, Ontario, June 30, 2026 Apotex Health Corp. announced that Health Canada has approved SEVMIA™ (semaglutide injection), making it...

VANCOUVER, Canada, June 17, 2026 LIR Life Sciences Corp. announced the successful completion of its comparative preclinical animal study...

June 10, 2026 – Taipei, Taiwan Caliway Biopharmaceuticals announced new preclinical data demonstrating the potential of its proprietary fat-reduction...

Plainsboro, New Jersey and Bagsværd, Denmark, June 7, 2026 Novo Nordisk has unveiled compelling Phase 3 clinical data for...

BAGSVÆRD, Denmark, June 3, 2026 Novo Nordisk has announced the launch of Wegovy® pill (semaglutide tablets) in the United...

TARRYTOWN, N.Y., June 4, 2026 Regeneron Pharmaceuticals has unveiled a broad slate of new clinical and preclinical research across...